vs
Side-by-side financial comparison of Church & Dwight (CHD) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Church & Dwight is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.0× SELECT MEDICAL HOLDINGS CORP). Church & Dwight runs the higher net margin — 14.7% vs 4.5%, a 10.2% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (5.0% vs 0.1%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (5.3% CAGR vs -1.4%).
Church & Dwight Co., Inc., is an American consumer goods company focusing on personal care, household products, and specialty products. The company was founded in 1847 and is headquartered in Ewing, New Jersey. It is the parent company of well-known brands such as Arm & Hammer, Trojan, OxiClean, and First Response. In 2022, Church & Dwight reported annual revenue of $5.4 billion. The company's products and services include a wide range of consumer goods, including laundry detergent, air fresh...
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
CHD vs SEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.4B |
| Net Profit | $216.3M | $63.8M |
| Gross Margin | 46.4% | — |
| Operating Margin | 19.8% | 6.9% |
| Net Margin | 14.7% | 4.5% |
| Revenue YoY | 0.1% | 5.0% |
| Net Profit YoY | -4.5% | -14.7% |
| EPS (diluted) | $0.91 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.5B | $1.4B | ||
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.5B | $1.3B |
| Q1 26 | $216.3M | $63.8M | ||
| Q4 25 | $143.5M | $20.2M | ||
| Q3 25 | $182.2M | $28.8M | ||
| Q2 25 | $191.0M | $40.6M | ||
| Q1 25 | $220.1M | $56.7M | ||
| Q4 24 | $189.2M | $-16.1M | ||
| Q3 24 | $-75.1M | $55.6M | ||
| Q2 24 | $243.5M | $77.6M |
| Q1 26 | 46.4% | — | ||
| Q4 25 | 45.8% | — | ||
| Q3 25 | 45.1% | — | ||
| Q2 25 | 43.0% | — | ||
| Q1 25 | 45.0% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 47.1% | — |
| Q1 26 | 19.8% | 6.9% | ||
| Q4 25 | 16.2% | 4.6% | ||
| Q3 25 | 16.1% | 5.4% | ||
| Q2 25 | 17.4% | 6.5% | ||
| Q1 25 | 20.1% | 8.3% | ||
| Q4 24 | 16.2% | 1.6% | ||
| Q3 24 | -6.1% | 4.3% | ||
| Q2 24 | 22.3% | 5.8% |
| Q1 26 | 14.7% | 4.5% | ||
| Q4 25 | 8.7% | 1.4% | ||
| Q3 25 | 11.5% | 2.1% | ||
| Q2 25 | 12.7% | 3.0% | ||
| Q1 25 | 15.0% | 4.2% | ||
| Q4 24 | 12.0% | -1.2% | ||
| Q3 24 | -5.0% | 4.4% | ||
| Q2 24 | 16.1% | 6.1% |
| Q1 26 | $0.91 | $0.35 | ||
| Q4 25 | $0.60 | $0.17 | ||
| Q3 25 | $0.75 | $0.23 | ||
| Q2 25 | $0.78 | $0.32 | ||
| Q1 25 | $0.89 | $0.44 | ||
| Q4 24 | $0.76 | $-0.12 | ||
| Q3 24 | $-0.31 | $0.43 | ||
| Q2 24 | $0.99 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $503.4M | $25.7M |
| Total DebtLower is stronger | $2.2B | $1.8B |
| Stockholders' EquityBook value | — | $2.1B |
| Total Assets | $9.0B | $6.0B |
| Debt / EquityLower = less leverage | — | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $503.4M | $25.7M | ||
| Q4 25 | $409.0M | $26.5M | ||
| Q3 25 | $305.3M | $60.1M | ||
| Q2 25 | $923.2M | $52.3M | ||
| Q1 25 | $1.1B | $53.2M | ||
| Q4 24 | $964.1M | $59.7M | ||
| Q3 24 | $752.1M | $191.5M | ||
| Q2 24 | $491.7M | $111.2M |
| Q1 26 | $2.2B | $1.8B | ||
| Q4 25 | $2.2B | $1.8B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $2.2B | $1.8B | ||
| Q1 25 | $2.2B | $1.8B | ||
| Q4 24 | $2.2B | $1.7B | ||
| Q3 24 | $2.2B | $3.1B | ||
| Q2 24 | $2.2B | $3.6B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $4.0B | $1.7B | ||
| Q3 25 | $4.2B | $1.7B | ||
| Q2 25 | $4.4B | $1.7B | ||
| Q1 25 | $4.6B | $1.7B | ||
| Q4 24 | $4.4B | $1.7B | ||
| Q3 24 | $4.2B | $1.9B | ||
| Q2 24 | $4.3B | $1.4B |
| Q1 26 | $9.0B | $6.0B | ||
| Q4 25 | $8.9B | $5.9B | ||
| Q3 25 | $9.1B | $5.7B | ||
| Q2 25 | $8.8B | $5.7B | ||
| Q1 25 | $9.0B | $5.7B | ||
| Q4 24 | $8.9B | $5.6B | ||
| Q3 24 | $8.7B | $8.0B | ||
| Q2 24 | $8.8B | $7.9B |
| Q1 26 | — | 0.88× | ||
| Q4 25 | 0.55× | 1.06× | ||
| Q3 25 | 0.52× | 1.03× | ||
| Q2 25 | 0.50× | 1.10× | ||
| Q1 25 | 0.48× | 1.03× | ||
| Q4 24 | 0.51× | 1.01× | ||
| Q3 24 | 0.53× | 1.62× | ||
| Q2 24 | 0.51× | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHD
| Household Products | $641.6M | 44% |
| Personal Care Products | $476.1M | 32% |
| Consumer International | $273.9M | 19% |
| Specialty Products Division | $77.7M | 5% |
SEM
Segment breakdown not available.
